Oncology Research2026，Vol.34Issue(3)：P.502-522,21.DOI:10.32604/or.2025.071034
Combinational Inhibition of the eIF4F Complex,AKT1,and EZH2 Enhances Anticancer Effects in BRAFV600E Mutant A375 Melanoma Cells
Yuanxin Miao 1Fengyun Hao 2Sae Hwi Ki3
作者信息
- 1. Department of Plastic and Reconstructive Surgery,Inha University School of Medicine,Incheon,22332,Republic of Korea Department of Plastic Surgery,The Affiliated Hospital of Qingdao University,Qingdao,266003,China
- 2. Department of Pathology,The Affiliated Hospital of Qingdao University,Qingdao,266003,China
- 3. Department of Plastic and Reconstructive Surgery,Inha University School of Medicine,Incheon,22332,Republic of Korea Department of Plastic and Reconstructive Surgery,Inha University Hospital,Incheon,22332,Republic of Korea
- 折叠
摘要
关键词
Melanoma/B-raf proto-oncogene serine/threonine kinase-inhibitor/eukaryotic initiation factor 4F complex inhibitor/extracellular signal-regulated kinases 1/2/enhancer of zeste homolog 2/AKT serine/threonine kinase 1/Bcl-2 modifying factor分类
医药卫生引用本文复制引用
Yuanxin Miao,Fengyun Hao,Sae Hwi Ki..Combinational Inhibition of the eIF4F Complex,AKT1,and EZH2 Enhances Anticancer Effects in BRAFV600E Mutant A375 Melanoma Cells[J].Oncology Research,2026,34(3):P.502-522,21.
